• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Activation Failure (3270)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/19/2019
Event Type  Injury  
Event Description
It was reported that the stent is not fully apposed to the vessel wall.The chronic total occluded (cto) target lesion was located in the moderately tortuous and severely calcified right superficial femoral artery (sfa).A 7x120x130cm eluvia drug-eluting vascular stent system was placed on (b)(6) 2019.Follow-up of the lesion was performed on (b)(6) 2019 using echo and angiography.It was reported that "there might be gap between the outside of the stent and the vessel wall".However, it was judged that a definitive diagnosis would not be possible without an examination using an angioscope or intravascular ultrasound.It was decided to perform an examination again.On the day of the re-examination, the findings of the optical frequency domain imaging (ofdi) and angioscopy, morphologically, displayed no aneurysm.On (b)(6) 2019, the patient returned and was hospitalized for examination.On (b)(6) 2019, the patient was planned to have left sfa treatment and right sfa vascular endoscope, ofdi inspection and checked by ivus.A stent graft insertion has been performed.There were no patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC SCIMED, INC
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10221019
MDR Text Key197215775
Report Number2134265-2020-08720
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 07/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/01/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number24653
Device Catalogue Number24653
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/10/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age89 YR
-
-